Status:

COMPLETED

Efficacy and Safety of Miltefosine or Thermotherapy for Cutaneous Leishmaniasis in Colombia.

Lead Sponsor:

Universidad de Antioquia

Collaborating Sponsors:

Dirección de Sanidad del Ejército de Colombia (DISAN)

Ministerio de Salud y Protección Social, Colombia

Conditions:

Cutaneous Leishmaniasis

Eligibility:

MALE

18-40 years

Phase:

PHASE3

Brief Summary

Cutaneous leishmaniasis (CL) is a worldwide disease, endemic in 88 countries, that has shown an increasing incidence the last two decades. It is estimated that in 2005, about of 20,000 new cases of CL...

Detailed Description

Evaluation of Efficacy and Safety of Miltefosine for Cutaneous Leishmaniasis in Colombia Leishmaniasis is taking dramatic dimensions in Colombia, due to its rapid expansion, reemergence (which has mad...

Eligibility Criteria

Inclusion

  • Inclusion Criteria:
  • Parasitologically proven cases of CL based on positive smear and/or culture.
  • Patients belonging to the National Colombian Army.
  • Otherwise healthy subjects on the basis of medical history, physical examination and results of blood test (if seemed necessary by the physician)
  • Age 18-40 years.
  • Willing to participate in the study, sign the informed consent , to go to the scheduled visits and to the follow-up visits.
  • Abstain to receive any other treatment for CL during the trial and follow-up periods.
  • Non purulent lesions.
  • Mentally sane volunteers.
  • No Leishmaniasis treatment in the six months prior to the recruitment.
  • Number of lesions no more than 5
  • Exclusion criteria:
  • None of the lesions must be close to the anal, oral and nasal mucosa, or next to the urogenital and anal canal.
  • Serious systemic illnesses (as judged by the physician)
  • Patients with mucosal compromise.
  • Patients with diffuse Leishmaniasis ( defined as 10 or more cutaneous lesions and negative Montenegro's test)

Exclusion

    Key Trial Info

    Start Date :

    June 1 2006

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ACTUAL

    End Date :

    December 1 2009

    Estimated Enrollment :

    437 Patients enrolled

    Trial Details

    Trial ID

    NCT00471705

    Start Date

    June 1 2006

    End Date

    December 1 2009

    Last Update

    January 16 2019

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    Program for Research and Control in Tropical Diseases - PECET

    Medellín, Antioquia, Colombia, 1226